内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Evommune, Inc.

EVMN · NYSE · CIK 0002044725 · Healthcare · Biotechnology

内部人信号

当前没有活跃买入信号

2 qualifying P purchase groups
当前 180 天评分窗口

18 同一窗口内观察到的 Form 4 交易行
9 sales · 7 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2026-07-08 · Carver Kyle · $13.3K

为什么没有活跃信号？

买入活动存在
近期买入2 qualifying line group(s)
近期卖出中等
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Patel Jeegar PravinkumarChief Scientific Officer
○▼○▼
Pena Luis C.President & CEO
▼▼○
Carver KyleChief Financial Officer
○▼●
Drew Janice SuzannChief of Dev. Operations
○▼
Moss Gregory S.Chief Business & Legal Officer
○▼
Cohen David EDirector
▼
● 买入▼ 卖出○ 其他

Showing the six most active owners; 1 additional owner(s) remain in Form 4 申报证据.

买方广度与集中度

合资格买方2
买入集中度91%最大买方： KIRSCH ARTHUR S · $133.0K
聚集买入 · 15天2 insiders峰值活动： 2026-07-07–2026-07-08

Roles in the peak window: Chief Financial Officer, Director. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2026-07-08 · Carver Kyle.

近期 Form 4 活动

7买入
9卖出
34其他 Form 4 交易行
33SEC 申报 · 365天
买入2 qualifying P line(s) · 180 days
卖出9 sale line(s) · 仅供背景
其他7 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
2,892,407
上期报告
2,876,209
日均成交量
749,525
回补天数
3.9

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-07-08Carver Kyle买入 (P)Common Stock1,000USD 13.26USD 13,260SEC 申报 ↗
2026-07-07KIRSCH ARTHUR S买入 (P)Common Stock10,000USD 13.30USD 133,000SEC 申报 ↗
2025-12-19Hopfner Robert Lorne买入 (P)Common Stock1,000USD 17.35USD 17,350SEC 申报 ↗
2025-11-07Verduyn-van Weegen Felice Isabel买入 (P)Common Stock1,562,500USD 16.00USD 25,000,000SEC 申报 ↗
2025-11-07RA CAPITAL MANAGEMENT, L.P.买入 (P)Common Stock1,250,000USD 16.00USD 20,000,000SEC 申报 ↗
2025-11-07LSP 7 Cooperative UA买入 (P)Common Stock1,562,500USD 16.00USD 25,000,000SEC 申报 ↗

Form 4 申报证据

50 transaction lines in the latest 365-day window; 50 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-30Pena Luis C.奖励／授予 (A)Common Stock1,115USD 7.02USD 7,827SEC 申报 ↗
2026-07-08Carver Kyle买入 (P)Common Stock1,000USD 13.26USD 13,260SEC 申报 ↗
2026-07-07KIRSCH ARTHUR S买入 (P)Common Stock10,000USD 13.30USD 133,000SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-30Pena Luis C.奖励／授予 (A)Common Stock1,115USD 7.02USD 7,827SEC 申报 ↗
2026-07-08Carver Kyle买入 (P)Common Stock1,000USD 13.26USD 13,260SEC 申报 ↗
2026-07-07KIRSCH ARTHUR S买入 (P)Common Stock10,000USD 13.30USD 133,000SEC 申报 ↗
2026-06-22Pena Luis C.卖出 (S)Common Stock7,438USD 22.71USD 168,917SEC 申报 ↗
2026-06-22Patel Jeegar Pravinkumar卖出 (S)Common Stock1,488USD 22.50USD 33,480SEC 申报 ↗
2026-06-22Patel Jeegar Pravinkumar期权行权／转换 (M)Common Stock1,488USD 3.84USD 5,714SEC 申报 ↗
2026-06-22Drew Janice Suzann卖出 (S)Common Stock20,000USD 22.63USD 452,600SEC 申报 ↗
2026-06-22Drew Janice Suzann期权行权／转换 (M)Common Stock20,000USD 3.15USD 63,063SEC 申报 ↗
2026-06-02Cohen David E卖出 (S)Common Stock6,056USD 20.33USD 123,094SEC 申报 ↗
2026-06-01Pena Luis C.卖出 (S)Common Stock16,787USD 22.74USD 381,736SEC 申报 ↗
2026-06-01Patel Jeegar Pravinkumar卖出 (S)Common Stock16,687USD 22.74USD 379,462SEC 申报 ↗
2026-06-01Patel Jeegar Pravinkumar期权行权／转换 (M)Common Stock13,512USD 3.84USD 51,886SEC 申报 ↗
2026-05-28Moss Gregory S.卖出 (S)Common Stock14,223USD 22.83USD 324,711SEC 申报 ↗
2026-05-28Moss Gregory S.期权行权／转换 (M)Common Stock14,223USD 1.71USD 24,321SEC 申报 ↗
2026-05-28Carver Kyle卖出 (S)Common Stock18,175USD 22.84USD 415,117SEC 申报 ↗
2026-05-28Carver Kyle期权行权／转换 (M)Common Stock15,000USD 2.99USD 44,850SEC 申报 ↗
2026-02-17LSP 7 Cooperative UA奖励／授予 (A)Common Stock358,680USD 27.88USD 9,999,998SEC 申报 ↗
2026-02-17Verduyn-van Weegen Felice Isabel奖励／授予 (A)Common Stock358,680USD 27.88USD 9,999,998SEC 申报 ↗
2026-02-17Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M.奖励／授予 (A)Common Stock35,868USD 27.88USD 1,000,000SEC 申报 ↗
2025-12-19Hopfner Robert Lorne买入 (P)Common Stock1,000USD 17.35USD 17,350SEC 申报 ↗
2025-12-09Pena Luis C.代扣税 (F)Common Stock28,138USD 17.84USD 501,982SEC 申报 ↗
2025-12-09Patel Jeegar Pravinkumar代扣税 (F)Common Stock7,513USD 17.84USD 134,032SEC 申报 ↗
2025-12-09Moss Gregory S.代扣税 (F)Common Stock13,624USD 17.84USD 243,052SEC 申报 ↗
2025-12-09Drew Janice Suzann代扣税 (F)Common Stock5,074USD 17.84USD 90,520SEC 申报 ↗
2025-12-09Carver Kyle代扣税 (F)Common Stock13,290USD 17.84USD 237,094SEC 申报 ↗
2025-12-09Bauer Eugene代扣税 (F)Common Stock1,478USD 17.84USD 26,368SEC 申报 ↗
2025-11-07Verduyn-van Weegen Felice Isabel买入 (P)Common Stock1,562,500USD 16.00USD 25,000,000SEC 申报 ↗
2025-11-07Verduyn-van Weegen Felice IsabelC (C)Common Stock3,367,133USD —USD —SEC 申报 ↗
2025-11-07RA CAPITAL MANAGEMENT, L.P.买入 (P)Common Stock1,250,000USD 16.00USD 20,000,000SEC 申报 ↗
2025-11-07RA CAPITAL MANAGEMENT, L.P.C (C)Common Stock2,208,770USD —USD —SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码EVMN
CIK0002044725
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所NYSE

数据覆盖

本地 Form 4 历史50 transaction lines from 2025-11-07 to 2026-09-30
7 P purchase lines · 9 S sale lines · 34 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.